barium has been researched along with 24,25-dihydroxyvitamin d 3 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caffrey, JM; Farach-Carson, MC | 1 |
Guggino, SE; Takeuchi, K | 1 |
2 other study(ies) available for barium and 24,25-dihydroxyvitamin d 3
Article | Year |
---|---|
Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells.
Topics: 24,25-Dihydroxyvitamin D 3; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Barium; Calcifediol; Calcitriol; Calcium; Calcium Channels; Cell Line; Dihydropyridines; Kinetics; Membrane Potentials; Osteosarcoma; Rats; Tumor Cells, Cultured | 1989 |
24R,25-(OH)2 vitamin D3 inhibits 1alpha,25-(OH)2 vitamin D3 and testosterone potentiation of calcium channels in osteosarcoma cells.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Barium; Calcitriol; Calcium Channels; Dose-Response Relationship, Drug; Osteosarcoma; Pertussis Toxin; Rats; Testosterone; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1996 |